News Website

Item of Interest: NIH announces finalists of endometriosis diagnostics competition - National Institute of Child Health and Human Development

Item of Interest: NIH announces finalists of endometriosis diagnostics competition National Institute of Child Health and Human Development

Published: March 13, 2025, 1 p.m.

Read Full Article

Comparison of diagnostic tests for chronic endometritis and endometrial dysbiosis in recurrent implantation failure: Impact on pregnancy outcomes - Nature.com

Comparison of diagnostic tests for chronic endometritis and endometrial dysbiosis in recurrent implantation failure: Impact on pregnancy outcomes Nature.com

Published: March 10, 2025, 3:12 p.m.

Read Full Article

Global Endometriosis Treatment Market Set for Robust Growth, Projected to Reach USD 6,297.2 million by 2035 amid Advancements in Diagnostics and Emerging Targeted Therapies | FMI - Yahoo Finance

Global Endometriosis Treatment Market Set for Robust Growth, Projected to Reach USD 6,297.2 million by 2035 amid Advancements in Diagnostics and Emerging Targeted Therapies | FMI Yahoo Finance

Published: March 4, 2025, 3:30 p.m.

Read Full Article

New Proteomics US testing lab opens door to vast diagnostic market - MSN

New Proteomics US testing lab opens door to vast diagnostic market MSN

Published: March 3, 2025, 6:42 p.m.

Read Full Article

'People with endometriosis earn less – after my diagnostic surgery I understand why' - Women's Health UK

'People with endometriosis earn less – after my diagnostic surgery I understand why' Women's Health UK

Published: March 3, 2025, 6:17 a.m.

Read Full Article

FZD7 Identified As Key Diagnostic Gene Linked To Ferroptosis Resistance - Evrim Ağacı

FZD7 Identified As Key Diagnostic Gene Linked To Ferroptosis Resistance Evrim Ağacı

Published: March 1, 2025, 9:01 a.m.

Read Full Article

Identification of FZD7 as a potential ferroptosis-related diagnostic gene in endometriosis by bioinformatics analysis - Nature.com

Identification of FZD7 as a potential ferroptosis-related diagnostic gene in endometriosis by bioinformatics analysis Nature.com

Published: Feb. 28, 2025, 10:34 a.m.

Read Full Article

Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ – An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. - Markets Insider

Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ – An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. Markets Insider

Published: Feb. 25, 2025, 1:10 p.m.

Read Full Article

Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ - An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. - The Manila Times

Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ - An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. The Manila Times

Published: Feb. 25, 2025, 10:48 a.m.

Read Full Article

Cicero Diagnostics, Inc. Announces the Release of - GlobeNewswire

Cicero Diagnostics, Inc. Announces the Release of GlobeNewswire

Published: Feb. 25, 2025, 10:46 a.m.

Read Full Article

Latest Articles

Item of Interest: NIH announces finalists of endometriosis diagnostics competition - National Institute of Child Health and Human Development

Comparison of diagnostic tests for chronic endometritis and endometrial dysbiosis in recurrent implantation failure: Impact on pregnancy outcomes - Nature.com

Global Endometriosis Treatment Market Set for Robust Growth, Projected to Reach USD 6,297.2 million by 2035 amid Advancements in Diagnostics and Emerging Targeted Therapies | FMI - Yahoo Finance

New Proteomics US testing lab opens door to vast diagnostic market - MSN

'People with endometriosis earn less – after my diagnostic surgery I understand why' - Women's Health UK

FZD7 Identified As Key Diagnostic Gene Linked To Ferroptosis Resistance - Evrim Ağacı

Identification of FZD7 as a potential ferroptosis-related diagnostic gene in endometriosis by bioinformatics analysis - Nature.com

Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ – An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. - Markets Insider

Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ - An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. - The Manila Times

Cicero Diagnostics, Inc. Announces the Release of - GlobeNewswire

Subscribe to Our Newsletter